Xenon Pharmaceuticals financial statements

제논 파머슈티컬NASDAQ:XENE · Nasdaq · Healthcare · sector #17
$36.57-2.66%
2026-10-06 close

Xenon Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$279M.

Reported results

Xenon Pharmaceuticals notifications

Quantus Signal · live data · not investment advice · Privacy Policy